Galmed Pharmaceuticals (GLMD) Assets Average (2014 - 2025)

Galmed Pharmaceuticals' Assets Average history runs 12 years deep, the most recent figure standing at $20.1 million for Q4 2025.

• In Q4 2025, Assets Average rose 1.93% year-over-year to $20.1 million; the TTM figure through Dec 2025 stood at $20.1 million (up 1.93% YoY), while the FY2025 annual figure was $18.6 million, up 5.69% from the prior year.
• Assets Average was $20.1 million for Q4 2025 at Galmed Pharmaceuticals, down from $22.3 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $56.4 million in Q1 2021 to a low of $7.2 million in Q2 2023.
• Historically, Assets Average has averaged $25.0 million across 5 years, with a median of $19.9 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Assets Average tumbled 73.42% in 2023, then surged 92.54% in 2024.
• A 5-year view of Assets Average shows it stood at $40.5 million in 2021, then slumped by 53.73% to $18.7 million in 2022, then fell by 8.45% to $17.1 million in 2023, then increased by 15.13% to $19.7 million in 2024, then rose by 1.93% to $20.1 million in 2025.
• The last three Assets Average figures came in at $20.1 million (Q4 2025), $22.3 million (Q3 2025), and $20.8 million (Q2 2025), per Business Quant data.